The project aims to increase the technological readiness level from TRL3 to TRL4 for a portable ultrasound measurement complex for non-invasive assessment of bone and muscle tissue quality. Additional pre-marketing activities will be carried out to understand customer needs, build a business model and survey stakeholders. The main objectives of the 8-month project are hardware optimization; acquisition and pre-processing software; artificial intelligence feature extraction; validation in phantoms and biological samples; documentation and dissemination; pre-marketing activities. Target groups: postmenopausal women, diabetics, athletes, rehabilitation groups and the elderly. Environmental benefits include the absence of radiation, low energy consumption and recyclable components, supporting the Green Deal and EU sustainability goals
Key components of BoMUS technology.
Benefit to society:The BoMUS system will provide unique health benefits to society, as no system in the world offers simultaneous quantification of cortical bone porosity and muscle fat in a portable, non-invasive format. The device combines dual-mode ultrasound probing and artificial intelligence algorithms to quickly and accurately determine key structural parameters such as cortical thickness (CTh) and intracortical porosity (CPo) in bone, as well as intermuscular adipose tissue (IMAT) content in muscle. BoMUS as a compact, laptop-powered, radiation-free device will be suitable for use in both clinical settings, home monitoring, and sports medicine. Projected high sensitivity (at least 85%) and repeatability (90% or more) will provide accurate and reliable results that enable individuals and medical professionals to perform early prevention, reduce fracture risk, and support active, healthy aging.
Projected market niche for ultrasonic complex BoMUS.
Participating scientists
